Calendar Alligator Bioscience AB London S.E.

Equities

Market Closed - London S.E. Other stock markets 10:52:01 2021-11-17 EST			5-day change	1st Jan Change
2.508 ^SEK	-66.28%		+123.96%	+303.28%

05-14	Alligator Bioscience Announces Initiation of an Investigator-Initiated Phase 1 Clinical Study of Mitazalimab in Local Advanced Pancreatic Cancer	CI
05-06	Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024

63.4X2xN11kR2V9XQeGFpE7yeGLba4Z1-ZJLmY3ZYTu-vs.iBXVcgpXFgoqcFLTdPNph4rbJu9evN8RfiFSBvy5qIKHB-Z4cCErCRoUdA~f12fa216ef500ee57f84610759fc6b1d

2024-07-11 02:00	Q2 2024 Earnings Release
2024-10-24 02:00	Q3 2024 Earnings Release
2025-02-12	Q4 2024 Earnings Release (Projected)
2025-04-28	Q1 2025 Earnings Release (Projected)
2025-07-09	Q2 2025 Earnings Release (Projected)
2025-10-22	Q3 2025 Earnings Release (Projected)

2024-05-07 08:00	Annual General Meeting
2024-05-06 09:00	Q1 2024 Earnings Call
2024-05-06 02:00	Q1 2024 Earnings Release
2024-03-14 06:30	Extraordinary Shareholders Meeting
2024-02-09 08:00	Q4 2023 Earnings Call
2024-02-08 02:00	Q4 2023 Earnings Release
2024-01-29 10:00	Mitazalimab OPTIMIZE-1 Phase 2 Study Results Call
2024-01-24 03:15	Redeye Theme: Fight Cancer
2023-12-01 08:00	Capital Markets Day
2023-10-26 06:30	Q3 2023 Earnings Call
2023-10-26 02:00	Q3 2023 Earnings Release
2023-07-13 10:00	Q2 2023 Earnings Call
2023-07-13 02:00	Q2 2023 Earnings Release
2023-05-09	Redeye Medtech Forum
2023-05-02	Annual General Meeting
2023-04-25	Redeye Orphan Drugs Event
2023-04-25 06:30	Q1 2023 Earnings Call
2023-04-25 02:00	Q1 2023 Earnings Release
2023-04-24 05:00	Extraordinary Shareholders Meeting
2023-04-17 13:30	American Association for Cancer Research Meeting - Abstract Number: 2939

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million SEK	Released Forecast Spread	5,40 2,04 164.94%	6,67 5,90 12.98%	15,1 10,6 42.16%	37,1 25,9 43.36%	61,9 97,1 -36.26%	261
EBITDA Million SEK	Released Forecast Spread	-203 -205 0.82%	-133 -130 -2.29%	-130 -132 1.18%	-181 -176 -3.01%	-238 -160 -48.62%	5,96
EBIT Million SEK	Released Forecast Spread	-215 -211 -1.66%	-144 -142 -1.56%	-142 -143 1.28%	-193 -185 -4.34%	-249 -171 -45.41%	-2,29
Earnings before Tax (EBT) Million SEK	Released Forecast Spread	-210 -210 -0.06%	-143 -141 -1.59%	-142 -143 1.06%	-193 -184 -4.91%	-249 -146 -70.47%	-6,11
Net income Million SEK	Released Forecast Spread	-210 -210 -0.06%	-143 -141 -1.59%	-142 -143 1.08%	-193 -184 -4.91%	-249 -171 -45.76%	-6,11
EPS SEK	Released Forecast Spread	-2,94 -2,94 0.03%	-2,01 -1,98 -1.75%	-0,64 -1,63 60.82%	-0,88 -0,81 -8.96%	-0,55 -0,29 -88.81%	-0,46
Announcement Date		12/02/20	26/02/21	11/02/22	10/02/23	08/02/24	-

2024-05-20	ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00	EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-21	CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
2024-05-21	EVOTEC SE: Q1 2024 Earnings Release
2024-06-30	IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
2024-07-15 01:45	ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21	MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23	SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23	ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23	IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)

2024-05-17 02:00	BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 16:05	CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14	GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 16:05	NUVATION BIO INC.: Q1 2024 Earnings Release
2024-05-14 07:30	ABSCI CORPORATION: Q1 2024 Earnings Release
2024-05-14 01:50	BELITE BIO, INC: Q1 2024 Earnings Release
2024-05-13	POLARIS GROUP: Q1 2024 Earnings Release
2024-05-13 16:30	AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-13 07:00	APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-12 19:00	PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release